Solution Informationhelp
Enzyme: Tropomyosin alpha-1 chain
inhibitor: BDBM52817
substrate: n/a
 
Solution Type: Aqueous
pH at Preparation: n/a
Temp. Prep.: n/a
Comments: Assay Overview: The purpose of this assay is to determine dose response curves for compounds that confirmed activity in a set of previous experiments entitled, "Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF)" (AID 504635). This biochemical assay employs the visible fluorophore, IANBD (Ex ~ 485 nm; Em ~ 535 nm) attached to troponin C (TnC, the Ca2+ binding subunit of the RTF) to monitor the Ca2+ dependent changes in fluorescence arising from IANBD-labeled RTF. As designed, a decrease in the RTF fluorescence intensity at a fixed calcium concentration and wavelength in response to a test compound will indicate that a change in the RTF calcium sensitivity has occurred. This assay employs an EC70 calcium concentration (1.6 mM). Compounds are tested in triplicate using a 10-point, 1:3 dilution series starting at a nominal concentration of 71.5 uM. Protocol Summary: Prior to the start of
 
 

If you find an error in this entry please send us an E-mail